Jane Street Group, LLC Gilead Sciences, Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 425,341 shares of GILD stock, worth $37.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

425,341

Previous 745,002 42.91%

Holding current value

$37.5 Million

Previous $54.6 Million 46.52%

% of portfolio

0.03%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $20.2 Million - $23.3 Million	-319,661 Reduced 42.91%	425,341 $29.2 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $31.9 Million - $38.9 Million	445,861 Added 149.05%	745,002 $54.6 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $7.95 Million - $9.01 Million	108,443 Added 56.87%	299,141 $24.2 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $276,979 - $302,189	-3,746 Reduced 1.93%	190,698 $14.3 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $668,507 - $762,526	8,795 Added 4.74%	194,444 $15 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $43.3 Million - $49.3 Million	-559,654 Reduced 75.09%	185,649 $15.4 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $34.4 Million - $49.5 Million	552,756 Added 287.08%	745,303 $64 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $7.39 Million - $8.44 Million	124,039 Added 181.06%	192,547 $11.9 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $7.39 Million - $8.44 Million	124,039 Added 181.06%	192,547 $11.9 Million
Q2 2022 Aug 16, 2022	SELL	$57.72 - $65.01 $29.1 Million - $32.8 Million	-504,359 Reduced 88.04%	68,508 $4.23 Million
Q1 2022 May 17, 2022	BUY	$57.92 - $72.58 $18.8 Million - $23.5 Million	323,845 Added 130.05%	572,867 $34.1 Million
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $5.31 Million - $6.03 Million	81,864 Added 48.97%	249,022 $18.1 Million
Q3 2021 Nov 16, 2021	SELL	$67.69 - $73.03 $11.4 Million - $12.3 Million	-167,989 Reduced 50.12%	167,158 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $302,878 - $330,938	4,772 Added 1.44%	335,147 $23.1 Million
Q1 2021 May 18, 2021	SELL	$60.0 - $68.46 $8.32 Million - $9.49 Million	-138,663 Reduced 29.56%	330,375 $21.4 Million
Q4 2020 Feb 17, 2021	BUY	$56.65 - $64.55 $9.53 Million - $10.9 Million	168,274 Added 55.95%	469,038 $27.3 Million
Q3 2020 Nov 17, 2020	SELL	$62.1 - $78.08 $5.53 Million - $6.95 Million	-88,971 Reduced 22.83%	300,764 $19 Million
Q2 2020 Aug 17, 2020	SELL	$72.34 - $84.0 $21 Million - $24.4 Million	-290,207 Reduced 42.68%	389,735 $30 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $37.2 Million - $47.7 Million	594,199 Added 693.0%	679,942 $50.8 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $4.06 Million - $4.47 Million	-65,877 Reduced 43.45%	85,743 $5.57 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.39 Million - $1.53 Million	22,210 Added 17.16%	151,620 $9.61 Million
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $6.49 Million - $7.27 Million	-104,854 Reduced 44.76%	129,410 $8.74 Million
Q1 2019 May 16, 2019	BUY	$62.53 - $70.05 $5.44 Million - $6.09 Million	86,955 Added 59.03%	234,264 $15.2 Million
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $2.73 Million - $3.56 Million	-45,071 Reduced 23.43%	147,309 $9.21 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $2.66 Million - $2.95 Million	37,380 Added 24.12%	192,380 $14.9 Million
Q2 2018 Aug 15, 2018	BUY	$64.88 - $75.68 $3.58 Million - $4.18 Million	55,247 Added 55.38%	155,000 $11 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $15.6 Million - $19.1 Million	-214,849 Reduced 68.29%	99,753 $7.52 Million
Q4 2017 Feb 15, 2018	SELL	$71.15 - $83.52 $11.2 Million - $13.2 Million	-158,045 Reduced 33.44%	314,602 $22.5 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $34.1 Million - $40.4 Million	472,647	472,647 $38.3 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Gilead Sciences, Inc. Transaction History